Contribution: Industrial Research Assistance Program – Contributions to Firms
BioMedica Diagnostics Inc.
$10,000.00
Creating Innovative and Novel Viscoelastometric Base IVD Reagent Technology for Universal Platform Application
FY 2016-17 · 2016-05-16
Summary
A new approach for monitoring blood clotting profiles that will significantly improve the prediction of catastrophic bleeding or thrombotic risk in ambulatory, surgical and emergency clinical settings._x000D_
_x000D_
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Windsor|Windsor, Nova Scotia, Canada
Recipient Type
For-profit organization
Business Number
896490125
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
As published
Additional Information
The end date of this agreement has been modified by 105 days.
Additional Information (French)
La date de fin du présent accord a été changé (105 jours)
Agreement End Date
2018-08-31
Agreement Number
866468
Agreement Start Date
2016-05-16
Agreement Title
Creating Innovative and Novel Viscoelastometric Base IVD Reagent Technology for Universal Platform Application
Agreement Title (French)
Créer une nouvelle technologie innovante IVD réactive à base viscoélastique métrique pour l’application d’une plate-forme universelle
Agreement Type
Contribution
Agreement Value
$10,000.00
Amendment Date
2018-05-18
Amendment Number
3
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
A new approach for monitoring blood clotting profiles that will significantly improve the prediction of catastrophic bleeding or thrombotic risk in ambulatory, surgical and emergency clinical settings._x000D_
_x000D_
Description (French)
Une nouvelle approche pour la surveillance des profils de coagulation du sang, qui améliorera considérablement la prédiction d’hémorragie catastrophique ou risque thrombotique en milieu clinique ambulatoire, chirurgicaux et d’urgence.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Kings--Hants
Federal Riding (French)
Kings--Hants
Federal Riding Number
12007
NAICS Code
325410
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
896490125
Recipient City
Windsor|Windsor
Recipient Country
CA
Recipient Legal Name
BioMedica Diagnostics Inc.
Recipient Operating Name
BioMedica Diagnostics Inc
Recipient Postal Code
B0N 2T0
Recipient Province or Territory
NS
Recipient Type
F
Reference Number
172-2018-2019-Q1-866468
